ABSTRACT
Bile acids and bilirubin are synthesized by the fetal liver very early on during intrauterine life. The main fate of these compounds is to be transferred to the mother. This excretory role of the placenta is primarily determined by the ability of the trophoblast to transport them, which is believed to occur mainly by carrier-mediated processes. The aim of this study was to investigate the role of the cholephilic organic anion exchanger located in the fetal-facing plasma membrane of the human trophoblast in placental "biliary-like" function. No relationship between the magnitude of transplacental gradients for total bile acids and bilirubin was found. However, transport studies, which were carried out by using purified plasma membrane vesicles derived from the fetal-facing pole of the human trophoblast, revealed that ['4C]taurocholate transport was affected by both another bile acid (taurochenodeoxycholic acid) and a non-bile acid cholephilic organic anion (bromosulfophthalein). On plotting the ability of different major bile acid species to inhibit radiolabeled taurocholate uptake by these vesicles vc.r.rus their concentrations in fetal serum or the magnitude of their transplacental gradients, inverse relationships were found. Lower fetal serum concentrations and transplacental gradients wcre found for bile acid species with higher abilities to affect this transport and presumably to interact with the carrier. By contrast, the magnitude of the transplacental gradient for bile acid species was not correlated with their hydrophobic/hydrophilic balance, as would be expected if diffusion across the lipidic structures of the placental barrier would be the major pathway for the flux of bile acid across this organ. In summary, these results indicate that carriers located in the basal plasma membrane may play an important role in the control of the qualitative and quantitative fetalmaternal bile acid exchange. Moreover, they suggest that although both bile acids and bilirubin may share this pathway for access to the trophoblast, other additional mechanisms are probably responsible in part for the control of the magnitude of their transplacental gradients. ( Very early on in gestational life, the fetal liver is able to output of these compounds from both compartments. Escape efficiently synthesize bile acids. The main fate of these mole-from the fetal compartment into the maternal blood mainly cules is to be transferred to the maternal blood where the occurs by placental transfer, although small additional renal concentrations are markedly lower than those measured in the excretion into the amniotic fluid does also exist. If the enterofetal blood (I). The magnitude of this difference is established hepatic circulation is present in the fetus, its magnitude and by a dynamic equilibrium involving the rate of bile acid hence bile acids loss into the meconjum are assumed to be synthesis by both fetal and maternal livers, together with the negligible (2). By contrast, in healthy pregnant women, the liver is able to handle the additional supply of bile acids by bile acid steady-state is established with the existence of a greater concentration of these compounds in the fetal blood as compared with the maternal one. An important role in controlling the magnitude of this transplacental gradient is probably played by the ability and selectivity of the mechanisms involved in bile acid transfer across the trophoblast (2). Owing to the low permeability of lipid bilayers for anionic bile acid molecules (3), it is believed that transport processes more efficient than simple diffusion must underlie this function of the trophoblast. The existence of carrier systems for bile acids both in the basal (fetal-facing) and the brush-border (maternalfacing) membranes of this tissue has been reported previously (4-7). The substrate specificity of these carriers (8) may account in part for the selective exchange of bile acid species between the fetal and the maternal bile acid pools.
Bile acids are not the only cholcphilic compounds that the fetus must export to the mother. Bilirubin, which is produced by the fetus in considerable amounts every day and which is potentially toxic, specially for certain fetal tissues (namely, the nervous system), is transferred by the placenta as part of what can be called the "biliary-like" function of this organ. In the hepatocyte, no relevant interaction between major bile acid species and bilirubin at carrier protein level exists (9). However, in the human trophoblast, the available experimental evidence suggests that several cholephilic organic anions may interact with the bile acid carrier located in the basal plasma membrane (10). Thus, an interesting question arises as to how this excretory function of the human placenta differs from that of the adult liver.
Quantitative assessment of the functional efficiency of the placenta yields important information for obstetricians who have to investigate the overall well-being of the fetus in terms of nutritional supply and equilibrated placental and fetal growth. Until now, the most generalized parameters have been restricted to those provided by morphologic observations, such as the extent of infarctions or intervillous hematoma of the placental parenchyma, together with certain measurements. These include the weight and size of the placenta, the relationship between fetal weight at birth and gestational time, and the placentallfetal weight ratio. However, although such data are readily obtained, the information provided is very reduced. Attempts have been made to increase the accuracy of morphologic studies by developing computer-assisted measurement programs capable of semiautomatic histometric investigation of the human placenta (11, 12). Nevertheless, the development of new and readily available functional measurements would bc dcsirablc. In this scnsc, it can be hypothcsizcd that, if transplacental gradients of bile acids and/or bilirubin are directly affected by impairment in the excretory function of the placenta, determination of fetal and maternal serum concentrations for these compounds may provide useful diagnostic information to evaluate the health of the placenta in pregnancies unaccompanied by fetal or maternal liver disease.
METHODS

Chemicals.
Cholic acid, glycocholic acid, TC, CDC, glycochenodeoxycholic acid, TCDC, ursodeoxycholic acid, tauroursodeoxycholic acid, deoxycholic acid, ~~lycodeoxycholic acid, taurodeoxycholic acid, BSA, dihydroalprenolol, L-alanine, BSP, Tris, 3a-hydroxysteroid dehydrogenase, diaphorase, resazurin, and the substrates and enzyme!; necessary for activity determinations were purchased from Sigma Chemical Co. (St. Louis, MO). Glycoursodeoxycholic acid was from Calbiochem (San Dicgo, CA). All bile acids were more than 95% pure by thin-layer chromatography. Hepes was purchased from Boehringer (Mannheim GmbH, Germany). ~-[ '~~] a l a n i n e (specific radioactivity, 160 mCi/mmol) was obtained from Maternal and fetal serum samples. To investigate the magnitude of the transplacental gradients for several compounds, including some typical biliary excreted substances, peripheral blood samples from 20 healthy pregnant women were collected at term, a few minutes before de1iver:y. Twenty paired fetal blood samples were also obtained from the umbilical cord at birth. Selection of the mothers entering the study was carried out from among patients with -40 wk long of uncomplicated pregnancy who had no major disease. The absence of hepatitis, cirrhosis, or any other hepatic or gastrointestinal disease was investigated at the time of selection. Samples from mothers showing antigenicity for toxoplasmosis and AIDS were also discarded. The study was approved by the Investigational Review Board of the University of Salamanca, Salamanca, Spain, and permission was obtained fr'om the mothers before samples were collected.
Preparation of human placental basal plasma membrane vesicles. bTPM vesicles were purified from normal human placentas obtained at term from the above-mentioned pregnancies after uncomplicated vaginal delivery at the Gynecology and Obstetrics Department of the "Virgen de la Vega" Hospital, Salamanca, Spain. The bTPM vesicles were prepared by a modification of the method of Kelley et al. (13) as described elsewhere (4). The purity and contamination of the preparations were assayed as indicated in a previous report (4) by dihydroalprenolol binding (14) as a marker for bTPM; alkaline phosphatase activity (EC 3.1.3.1) (15) as a marker for apical plasma membrane; L(+)-tartrate-sensitive acid phosphatase (EC 3.1.3.2) (16) as a marker for lysosomal membrane; glucose 6-phosphatase (EC 3.1.3.9) (17) as a marlter for microsoma1 membrane; and succinic dchydrogcnasc (EC 1.3.99.1) (18) as a marker for mitochondria1 membrane. The results for basal membrane enrichment and contamination by apical membrane are given in Table 1 . Both these results and those concerning contamination by intracellular membranes (data not shown) were similar to the parameters clcscribed elsewhere (4). The integrity and orientation of the bTPM vesicles obtained by this method have been reported previously (19). Vesicle preparations were stored in buffer A (250 mM sucrose, 100 mM KNO,, 10 mM MgCl,, 0.2 mM CaCl,, 10 mM Hepes~Tris, pH 7.40) at -80°C until used. Before carrying out the experiments the vesicles were first thawed and then diluted with buffer A to approximately 5 mg proteinimL for uptake experiments and 10 mg/mL for efRux experiments. Membranes were vesiculated by six passages through a 25-gauge needle. Protein was determined by a modification of the method of Lowry (20) 0.5% Triton X-100 almost abolishes radioactivity retention. Therefore, the radioactivity measured in the present study can be assumed to be mainly due to intravesicular TC. In uptake experiments, values were corrected for the radioactivity found on the filters when vesicles were added once the ice-cold stop solution had already been mixed with the incubation medium. Typically, 5 X lo4 dpm applied to the filters gave an average blank of less than 50 dpm. In the efRux experiments, total loaded radioactivity after 2 h (Q,) was measured by rapid filtration after adding 20 p L of the vesicle suspension and 80 p L of the incubation medium directly to 4 mL of ice-cold stop solution. Net efflux was calculated by subtracting the actual value of radioactivity found at 30 s of incubation time (Q,) from the Q, determined for each specific loaded vesicle preparation. Radioactivity on the filters was measured in a liquid scintillation spectrometer (LS-1800-Beckman, Beckman Instruments, Madrid, Spain) using the Ready Safe Scintillation Cocktail, also from Beckman, as scintillant. To perform efflux experiments, the vesicles were previously loaded with TC as follows: a double concentrated suspension of purified membrane preparation was diluted 1:l with buffer A containing 2 X C mM unlabeled TC plus approximately 5,000 dpm/pL [ 1 4 c ]~c , where C was the desired final concentration of T C plus [ 1 4 c ]~c .
Membrane vesicles were incubated with the buffer containing labeled and unlabeled TC at 25OC for 2 h before use.
Analytical methods. Bile acids were obtained from serum samples by liquid-solid extraction (22). Serum samples were diluted (1:4, volivol) with 0.4 M NH4HC0, and heated to 64°C for 2 h. Samples were centrifuged for 15 min at 5 000 X g. The resulting supernatants were heated again for 10 min and extracted using reverse phase octadecylsilane bonded silica cartridges (Sep-Pak, Waters-Millipore, Madrid, Spain). After washing the cartridges with water (10 mL), acetone (3 mL 10% in water) and water (10 mL), bile acids were recovered with 4 mL of methanol. This solution was filtered using a "Sample Clarification Kit" (Waters-Millipore) and dried. To carry out total bile acid measurement and HPLC, the sample was redissolved with 200 p L methanol. This procedure allows both an efficient elimination of serum components other than bile acids and also reconcentration of bile acids by about 20-fold, which is required to perform subsequent analytical procedures. Total bile acid concentrations were measured by a sensitive method based on the stoichiometric conversion of 3a-hydroxyl-bile acid into 3-keto-bile acid together with the generation of a fluorescent molecule of resorfin from one of resazurin by the sequential action of 3a-hydroxysteroid dehydrogenase and diaphorase in the presence of NAD+ as cofactor (23, 24). 
RESULTS
To investigate the magnitude of the transplacental gradient for several compounds, including some substances typically excreted by the biliary system, 20 paired, i.e. maternal and fetal, blood samples were collected before and immediately after the delivery, respectively. Table 2 shows the values of routine laboratory analyses carried out by conventional techniques. The values found in the serum of these women were consistent with the healthy state of these pregnant women at term. Pregnancy accounts for the high level of alkaline phosphatase which, in this case, should not be associated with cholestasis, as indicated by the low levels of serum bilirubin. Other parameters included in Table 2 usually considered as indicators of liver function suggest the absence of liver impairment. High serum levels of cholesterol and triglycerides are in the range usually seen in the third trimester of normal pregnancies.
Measurements carried out on serum samples from these mothers and their fetuses indicated that both total bilirubin and total bile acid concentrations were higher in the fetus, i.e. a transplacental gradient in the fetal-maternal direction for these compounds does exist (Fig. 1) . If we assume that the magnitude of transplacental gradients is inversely proportional to the capability of the compounds to cross the placental barrier, then it must be suggested that the placental transfer for bile acids must be more efficient than that for bilirubin. This rationale is consistent with the fact that easily crossing compounds such as 
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urea and glucose were found to have transplacental gradients of very small magnitude (Fig. 1) . However, this can be only partly true, because other factors in addition to placental transfer are involved in establishing serum fetal and maternal concentrations of these compounds. An important difference between the liver and the placenta with respect to the transport of lipophilic compounds is that bile acids and bilirubin are secreted into bile by the liver, as also occurs for cholesterol and phospholipids, whereas in the placenta the transfer of bile acids and bilirubin takes place in the opposite direction to that of the main flux for other lipidic compounds. The functional advantage of this difference is evident; the existence of a transplacental gradient for cholesterol and triglycerides (Fig. 31) provides the physical bases for the supply of these compounds from the maternal blood to the fetus and the placenta which use them mainly for their structural and hormonal requirements. As far as bile acids and bilirubin are concerned, the first step in their transfer from the fetus to the rnother is their transport across the basal plasma membrane of the trophoblast. At least for bile acids, a carrier-mediated system seems to be involved in this process (4). The system has been previously reported to behave as an anion exchanger (10, 19). In the current study, using highly enriched fetal-facing plasma membrane vesicles (Table 1) and radiolabeled TC, determinations of the rate of bile acid transport across this membrane were performed in the presence of other bile acid molecular species and a typical non-bile acid cholephilic organic anion, such as BSP.
As shown in Figure 2 , TC efflux from previously loaded vesicles was strongly affected by the presence in the incubation medium of TCDC, a TC analog lacking the hydroxyl group at C12. The loading of the membrane vesicles with 300 p M TCDC, in addition to 50 p M TC, significantly reduced the magnitude of TC efflux from the vesicles. This is not consistent with vesicle damage, because in this case an increased loss of vesicle content would be expected instead of greater TC retention in the presence of TCDC (10, 19). By contrast, TC efflux from preloaded bTPM vesicles was increased when 300 p M TCDC was placed in the extravesicular medium. This TCDCinduced trans-stimulating effect was not seen when the efflux of a non-bile acid compound, such as ~-[~~~] a l a n i n e , was investigated. 1,-Alaninc efffux, from vesicles that were preloaded by incubation for 2 h at 37OC with 100 pM L-alanine, was found to be not significantly different, as compared measurements carried out in the absencc (135 + 18 pmoll60 s/mg protein; n = 3) and in the presence (140 + 21 pmoll60 s/mg protein; n = 3) of 300 p M extravesicular TCDC. Additionally, experiments wherc TCDC was replaced by the cholephilic organic anion BSP were carried out. BSP is usually preferred to bilirubin because of its higher stability and easier handling. Figure 2 shows that, as was found for TCDC, BSP induced a significant cis-inhibition when located on the same side of the membrane as TC, and induced trans-stimulation when it was present on thc opposite sidc to TC. Thesc findings confirm and extend previous reports on the nature of this carrier as an anion exchanger system (10, 19). These results support thc interest in investigating the existence of any functional relationship between bile acid and bilirubin as far as their transfer across the placenta is concerned. Measurement of the concentrations of these two compounds in fetal and maternal blood revealed no significant correlation between the magnitude of their transplacental gradient (data not shown). Because fetal serum concentrations of these compounds are thc result of sevcral mechanisms, including both the rate of fetal and maternal production and the efficiency and vectoriality of placental transfer, these results may suggest either a different pathway as the major route for bile acid and bilirubin transport across the trophoblast and/or a markedly different rate of fetal plus maternal synthesis for both types of compounds. No relationship between the level of bile acids in fetal blood and the concentration of other structurally related or, by contrast, very different lipidic compounds, such as cholesterol and triglyccrides, respcctively, was found (data not shown).
Investigation of the relationship between the hydrophilic/ hydrophobic balance of bile acid species and their accumulation in fetal blood supports the concept that simple diffusion across the plasma membrancs of the trophoblast is not a major pathway in the placental transfer of these compounds, because if that would be the casc, lower accumulation within the fetal compartment would be expected for more lipophilic bile acid species, which is not in agreement with our observations (Fig. 3) .
The last sct of experiments was pcrformed to focus our investigation on the role of the basal plasma membrane of the human trophoblast in the selcction of bilc acid molecular species to be transported toward the mother. Because all the proper radiolabeled species are not available we performed the study according with thc following approximation. If it is assumed that, in our experimental conditions, the ability to inhibit TC transport is an indirect indicative of the ability to interact with the bile acid carrier, and hence to be transported across this membrane, it can be expected that molecular species able to induce higher TC transport inhibition also cross this membrane more efficiently. Accordingly, their transplacental gradient would be also expected to be lower. In this regard, Figure 4 shows that an inverse correlation exists between bilc acid-induced inhibition of TC transport across the fetal-facing membrane of the trophoblast and fetal serum concentrations for most of the major bile acid species. When comparison was made after taking into account maternal serum concentrations, i.e. considering transplacental gradients, as shown in Figure 5 , it was found that bile acids with a higher ability to interact with the carrier were actually more concentrated in the mother than in the fetus, whcreas molecular species with a poor ability to interact with the carrier remained accumulated in the fetal blood. Although nonlinear correlations 6001 1=0.002, NS.
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DISCUSSION
The intrauterine life of the human fetus depends on different and complex functions performed by the placenta. Among these functions, bidirectional transfer provides the substrates required for fetal nutrition and prevents the accumulation of potentially toxic metabolites in the fetal compartment. This flux of substances across the placental barrier occurs both by simple diffusion and by carrier-mediated transport processes. The results included in this report support the notion that cholephilic organic anions need to be transferred by specific carrier owing to the low permeability of the lipid bilayers to these compounds (3).
Previous studies have shown the existence of a significant correlation between the magnitude of the accumulation of both bilirubin and bile acids in the neonate (3 7). This may partially reflect the deficiencies in adequate conjugation but also the immaturity in sinusoidal and/or canalicular transport processes. However, during intrauterine life, the accumulation of bilirubin at the fetal side of the compartments separated by the placenta must be due to the result of both bilirubin production by the fetus and its limitation to cross the trophoblast. Our investigation concerning the relationship of thcse two aspects of placental excretory function reveals that although both bile acids and bilirubin probably interact with the anion-exchanger carrier located in the basal membrane of the trophoblast, the magnitude of their accumulation in the fetus does not seem to be directly related. Therefore, additional and independent processes may account for different overall transfer of these compounds across the placenta and/or metabolism by both the mother and the fetus.
Although the human fetus is capablc of bile acid synthesis, the rate of this metabolic pathway and pool size are lower than in the adult (38) (39) (40) . However, the results obtained in the present work confirm previous findings by other groups on the relative fetal and, to a lesser extent, also maternal hypercholanemia in uncomplicated pregnancies. Moreover, in spite of the large variability in the bile acid profiles of both fetal and maternal blood (I), these studies indicate that, in agreement with previous reports by other authors (41, 42) , in normal term infants at birth, bile acid profiles for major bile acid species are generally different from those of their mothers. With regard to the ratio of two major primary bile acid families in the fetal and adult bile acid pool, the mean value for the cholic acid:CDC ratio was 0.61 in the fetuses and 1.79 in their mothers. This has been interpreted (41) as being due to the immaturity of the 12a-hydroxylase enzyme system in the fetal liver (43) . Our results suggest that a lower ability of CDC, compared with the cholic acid family, to interact with the carrier responsible for entry into the trophoblast may also be involved in the differential accumulation of cholic acid versus CDC in the fetal compartment. This difference in the ability to cross the placenta may additionally contribute to increasing the cholic acid:CDC ratio in the mother. Thcsc findings are consistent with those obtained in other species, such as the sheep, where the transplacental transfer of CDC has been reported to occur very slowly (44) .
The statc of fetal hypercholancmia reflects not only an early development of the enzymc equipment needed by the fetal liver to synthcsize bile acids, but also the immaturity of thc enterohepatic circulation. Hepatic insufficiency with respect to bile acid transport in the fetal state (45) is compcnsated for by the placental transfer of these compounds toward thc mother. The fact that serum bile acid concentrations are markedly increased shortly after birth (37, 46, 47) supports the idea that the placenta plays a kcy role in the control of fetal cholanemia by compensating the immaturity of biliary function in the fetal liver. The available experimental data are also consistcnt with lcstasis, return to normal in the subsequcnt days or
